The goal of a generic drugmaker wouldn't be to actually overturn a big drug firm's patents.

FORBES: Magazine Article

The goal of any generic drug company must be to launch new drugs.

FORBES: Lilly, Other Drugmakers Rely On Patents

When Schering-Plough and Merck announced Nov. 19 they had been advised to change the scientific goal of a long-delayed clinical trial comparing the effectiveness of their blockbuster cholesterol Vytorin to a generic, the decision drew press scrutiny, criticism and a Congressional investigation.

FORBES: Magazine Article